0001179110-19-008540.txt : 20190709
0001179110-19-008540.hdr.sgml : 20190709
20190709081837
ACCESSION NUMBER: 0001179110-19-008540
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190708
FILED AS OF DATE: 20190709
DATE AS OF CHANGE: 20190709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Diane C.
CENTRAL INDEX KEY: 0001648010
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 19946366
MAIL ADDRESS:
STREET 1: 175 TOYOTA PLAZA, 7TH FLOOR
CITY: MEMPHIS
STATE: TN
ZIP: 38103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0306
4
2019-07-08
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001648010
Young Diane C.
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD, SUITE 220
HAMPTON
NJ
08827
0
1
0
0
SVP, Chief Medical Officer
Incentive Stock Option (right to buy)
2.71
2019-07-08
4
A
0
60000
0
A
2020-07-08
2029-07-08
Common Stock
60000
60000
D
Represents option granted by Issuer pursuant to its 2008 Stock Option and Incentive Plan.
25% vests on July 8, 2020 and the remainder vests quarterly (in equal amounts) over the subsequent 12 quarters.
/s/ Samuel B. Martin, attorney-in-fact for Diane C. Young
2019-07-09